ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Characterizing probiotic properties of the Saccharomyces cerevisiae ABO1 strain isolated from toddy palm nectar.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Cardiovascular diseases are strongly associated with high cholesterol levels, which also cause hypertension and diabetes. It is important to have optimal cholesterol levels for general well-being. This research is intended to screen, isolate, and identify probiotic yeast strains with cholesterol-reducing ability from toddy palm nectar. Out of 63 isolates, five strains ABO1, ABO11, ABO13, ABO20, and ABO21 had probiotic characteristics. Among the five isolates, ABO1 showed the highest probiotic traits and was characterized as Saccharomyces cerevisiae ABO1 by molecular-level characterization. Cholesterol reduction ability was determined using spectrophotometry and HPLC, and it was found that ABO1 recorded an 86.90% reduction, which is similar to the 86.74% reduction of the reference Saccharomyces boulardii strain. The other isolates had reduction levels of 65.23% (ABO11), 58.46% (ABO13), 14.09% (ABO20), and 12.79% (ABO21). The GC-MS analysis of 48-h cell-free culture medium revealed the presence of organic acids and bioactive metabolites with therapeutic values. Overall, the present work emphasizes the probiotic value of toddy palm nectar yeast strains with cholesterol-reducing activity, which opens the doors for possible human probiotic applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.